Exane Derivatives’s Linde LIN Stock Holding History

Exane Derivatives’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$72.6K	Sell	255 -1,835	-88%	-$573K	0.04%	288
2022 Q1	$674K	Sell	2,090 -1,958	-48%	-$605K	0.19%	139
2021 Q4	$1.54M	Sell	4,048 -26,072	-87%	-$8.45M	0.37%	55
2021 Q3	$9.02M	Buy	30,120 +20,165	+203%	+$6.13M	2.17%	4
2021 Q2	$2.89M	Sell	9,955 -19,688	-66%	-$5.74M	0.66%	25
2021 Q1	$11.3M	Buy	+29,643	New	+$7.69M	3.24%	2
2020 Q4	–	Sell	-243	Closed	-$59.6K	–	852
2020 Q3	$57.4K	Sell	243 -29,561	-99%	-$7.17M	0.02%	369
2020 Q2	$6.28M	Buy	+29,804	New	+$5.76M	1.68%	11
2020 Q1	–	Sell	-37,464	Closed	-$7.39M	–	726
2019 Q4	$7.99M	Buy	37,464 +34,949	+1,390%	+$7.04M	1.48%	11
2019 Q3	$487K	Buy	+2,515	New	+$487K	0.09%	167
2019 Q2	–	Sell	-114,984	Closed	-$21.5M	–	689
2019 Q1	$20.2M	Sell	114,984 -37,063	-24%	-$6.16M	3.98%	2
2018 Q4	$24.1M	Buy	+152,047	New	+$24M	4.33%	3

Other funds holding LIN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's LIN Position: Q2 2022 in Review

Exane Derivatives reduced its Linde (LIN) stake by 88% in Q2 2022, selling an estimated $573K and leaving 255 shares worth $72.6K. The position accounts for 0.04% of the portfolio, ranked #288.

Exane Derivatives first reported a position in LIN in Q4 2018 and has held it in 12 quarters since. The position peaked at $24.1M in Q4 2018. 1,420 funds tracked by Wall St. Rank hold LIN as of Q2 2022.

Exane Derivatives held 255 shares of Linde worth $72.6K as of Q2 2022.
Exane Derivatives sold 1,835 Linde shares in Q2 2022, an estimated $573K.
Linde made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #288 holding.
Exane Derivatives first reported a position in Linde in Q4 2018 and has held it in 12 quarters since.
Exane Derivatives's Linde position peaked at $24.1M in Q4 2018.
1,420 funds tracked by Wall St. Rank held Linde as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.